Evaxion Biotech A/S ADR (EVAX) Stock Price, Quote & News

Company Profile

Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1, a m...

Industry: Biotechnology

Sector: Healthcare

Phone: 45 53 53 18 50

Website: evaxion.ai

Address:

Dr. Neergaards Vej, 5th Floor, Horsholm, Denmark

Akwaba Aug. 21 at 6:55 PM

$EVAX is using AI to find ancient viral footprints that many cancer patients share. By putting these common targets into one single cocktail vaccine, they can treat thousands of patients with the exact same shot. This off-the-shelf method completely beats Moderna's hyper-personalized approach because it does not require making a slow, custom vaccine from scratch for every single person. It drives manufacturing costs down to a fraction of the price and makes the treatment instantly available for the masses. This tech will disrupt the multi-billion dollar oncology market. Holding long.But in since Yesterday!!!!

1 · Reply

Synaptric Aug. 21 at 3:29 PM

Thursday's double-digit moves from the mornings earnigns were decliners from the Bullish zone $AAP $RERE The noted rapid-sentiment-risers $EVAX and $BABA posted modest upside gains. The only Bearush zone stock $DQ gained over 6%.

0 · Reply

mikethemage Aug. 21 at 1:36 AM

$EVAX no

1 · Reply

mikethemage Aug. 21 at 1:04 AM

$EVAX

0 · Reply

mikethemage Aug. 20 at 9:14 PM

$EVAX it did not

0 · Reply

blackcat643 Aug. 20 at 8:58 PM

$EVAX cmon babes 2min,dont move and u close on 3.32+,thats huge,

0 · Reply

blackcat643 Aug. 20 at 8:31 PM

$EVAX cmon lil bro just break 3.42 in ah

0 · Reply

mikethemage Aug. 20 at 7:28 PM

$EVAX ah fail. Cya next year. Goodnight

0 · Reply

mikethemage Aug. 20 at 7:24 PM

$EVAX run you pig

0 · Reply

mikethemage Aug. 20 at 7:11 PM

$EVAX I should have sold at 4.48

2 · Reply

Evaxion Earnings Call Transcript: Q2 2026

Aug 20, 2026, 8:30 AM EDT - 4 days ago

Evaxion Earnings release: Q2 2026

Aug 20, 2026, 8:30 AM EDT - 4 days ago

Evaxion Slides: Q2 2026

Aug 20, 2026, 7:30 AM EDT - 4 days ago

Evaxion announces business update and second quarter 2026 financial results

Aug 17, 2026, 8:00 AM EDT - 7 days ago

Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine program

Aug 14, 2026, 8:00 AM EDT - 10 days ago

Evaxion to announce business update and second quarter 2026 financial results on August 20, 2026

2026-08-10T14:15:17.000Z - 14 days ago

Merck discloses 1.21M share holding in Evaxion Biotech

MRK

2026-07-17T11:40:27.000Z - 5 weeks ago

Evaxion Biotech to present EVX-01 clinical efficacy data at ESMO

Jul 17, 2026, 7:15 AM EDT - 5 weeks ago

Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026

2026-07-12T13:45:04.000Z - 6 weeks ago

Evaxion Biotech presents new data on EVX-V1

Jul 12, 2026, 9:30 AM EDT - 6 weeks ago

Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1

Jul 1, 2026, 8:00 AM EDT - 7 weeks ago

Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop

Jun 12, 2026, 3:00 AM EDT - 2 months ago

Evaxion receives Prix Galien UK Award for Best digital health solution

Jun 11, 2026, 2:00 AM EDT - 2 months ago

Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia

May 12, 2026, 9:30 AM EDT - 3 months ago

Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress

May 7, 2026, 8:30 AM EDT - 3 months ago

Evaxion Earnings Call Transcript: Q1 2026

May 7, 2026, 8:30 AM EDT - 3 months ago

Evaxion Earnings release: Q1 2026

May 7, 2026, 8:30 AM EDT - 3 months ago

Evaxion Slides: Q1 2026

May 7, 2026, 7:30 AM EDT - 3 months ago

Evaxion announces business update and first quarter 2026 financial results

May 4, 2026, 8:00 AM EDT - 4 months ago

Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026

2026-04-27T16:25:27.000Z - 4 months ago

Evaxion Biotech management to meet with Maxim

Apr 27, 2026, 8:00 AM EDT - 4 months ago

Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer

2026-04-17T19:15:15.000Z - 4 months ago

Evaxion says EVX-01 demonstrates 86% vaccine target precision in trial

Apr 17, 2026, 3:10 PM EDT - 4 months ago

Evaxion's AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial

2026-04-17T19:05:59.000Z - 4 months ago

Evaxion Biotech announces new data to be presented at AACR meeting

Apr 16, 2026, 11:30 AM EDT - 4 months ago

Evaxion concludes Annual General Meeting

2026-04-07T12:55:09.000Z - 4 months ago

Evaxion Biotech reports last patient visit in one-year extension of EVX-01 trial

MRK

Mar 30, 2026, 8:00 AM EDT - 5 months ago

Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress

Mar 19, 2026, 9:00 AM EDT - 5 months ago

Notice to convene Evaxion's Annual General Meeting

2026-03-09T20:11:13.000Z - 5 months ago